REFERENCES
1- Renehan AG, Tyson M, Egger M, Heller R, Zwahlen M: Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-578.
2- Hidayat K, Du X, Shi: BM Body fatness at a young age and risks of eight types of cancer: systematic review and meta-analysis of observational studies. Obes Rev . 2018;19:1385-1394.
3- Ma J, Huang M, Wang L, Ye W, Tong Y, Wang H: Obesity and risk of thyroid cancer: evidence from a meta-analysis of 21 observational studies. Med Sci Monit. 2015;21:283-91.
4- Wu C, Wang L, Chen W, Zou S, Yang A. Associations between body mass index and lymph node metastases of patients with papillary thyroid cancer: A retrospective study. Medicine (Baltimore) . 2017;Mar;96(9):e6202.
5- Dieringer P, Klass EM, Caine B, Smith-Gagen J: Associations between body mass and papillary thyroid cancer stage and tumor size: a population-based study. J Cancer Res Clin Oncol . 2015;141:93-8.
6- Trésallet C, Seman M, Tissier F, Buffet C, Lupinacci RM, Vuarnesson H, Leenhardt L, Menegaux F: The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices.Surgery. 2014;156:1145-52.
7- Grani G, Lamartina L, Montesano T, Ronga G, Maggisano V, Falcone R, Ramundo V, Giacomelli L, Durante C, Russo D, Maranghi M: Lack of association between obesity and aggressiveness of differentiated thyroid cancer. J Endocrinol Invest. 2019;42:85-90.
8- US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Barry MJ, Davidson KW, et al: Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement JAMA . 2017;317:1882-1887.
9- Clement SC, Kremer LCM, Verburg FA, Simmons JH, Goldfarb M, Peeters RP, et al: Balancing the benefits and harms of thyroid cancer surveillance in survivors of childhood, adolescent and young adult cancer: Recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. Cancer Treat Rev . 2018;63:28-39.
10- Yamashita S, Suzuki S, Suzuki S, Shimura H, Saenko V. Lessons from Fukushima latest findings of thyroid cancer after the Fukushima nuclear power plant accident. Thyroid . 2018;28:11-22.
11- Mukasa K, Noh JY, Kunii Y, Matsumoto M, Sato S, Yasuda S, Suzuki M, Ito K, Ito K: Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases. Thyroid. 2011;21:37-41.
12- Han JM, Kim TY, Jeon MJ, Yim JH, Kim WG, Song DE, Hong SJ, Bae SJ, Kim HK, Shin MH, Shong YK, Kim WB: Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population. Eur J Endocrinol. 2013;168:879-86.
13- Pasquali R, Casanueva F, Haluzik M, van Hulsteijn L, Ledoux S, Monteiro MP, Salvador J, Santini F, Toplak H, Dekkers OM: European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity. Eur J Endocrinol. 2020;182:G1-G32.
14- Pinsky PF: Principles of cancer screening. Surg Clin North Am . 2015;95:953-66.
15- Cham S, Zanocco K, Sturgeon C, Yeh MW, Harari A: Risk-based ultrasound screening for thyroid cancer in obese patients is cost-effective. Thyroid . 2014;24:975-86.
16- Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al: 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid.2016;26:1-133.
17- Castells I, Pardo N, Videla S, Giménez G, Llargues E, Simó O, Recasens MA, Guirao X, Mira X, Serrano A, Sanmartí A: Healthcare impact of introduction of thyroid ultrasound in a thyroid nodule pathology unit. Endocrinol Nutr . 2013;60:53-9.
18- Cibas ES, Ali SZ: NCI Thyroid FNA State of the science conference. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol . 2009;132:658-65.
19- Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al: ACR Thyroid imaging, reporting and data system (TI-RADS): White paper of the ACR TI-RADS Committee. Am Coll Radiol . 2017;14:587-595.
20- Lin JS, Bowles EJA, Williams SB, Morrison CC: Screening for Thyroid Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA . 2017;317:1888-1903.
21- Ahn HS, Kim HJ, Kim KH, Lee YS, Han SJ, Kim Y, Ko MJ, Brito JP: Thyroid cancer screening in South Korea increases detection of papillary cancers with no impact on other subtypes or thyroid cancer mortality.Thyroid . 2016;26:1535-1540.
22- O’Grady TJ, Gates MA, Boscoe FP: Thyroid cancer incidence attributable to overdiagnosis in the United States 1981-2011. Int J Cancer . 2015;137:2664-73.
23- Cronan JJ: Thyroid nodules: is it time to turn off the US machines?Radiology . 2008;247:602-4.
24- Morgan DJ, Dhruva SS, Wright SM, Korenstein D: Update on Medical Practices That Should Be Questioned in 2015. JAMA Intern Med . 2015;175:960-4.
25- Canaris GJ, Manowitz NR, Mayor G, Ridgway EC: The Colorado thyroid disease prevalence study. Arch Intern Med . 2000;160:526-34.
26- Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE: Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab2002;87:489-99.
27- Giorda CB, Carnà P, Romeo F, Costa G, Tartaglino B, Gnavi R: Prevalence, incidence and associated comorbidities of treated hypothyroidism: an update from a European population. Eur J Endocrinol . 2017;176:533-542.
28- Dekelbab BH, Abou Ouf HA, Jain I: Prevalence of elevated thyroid-stimulating hormone levels in obese children and adolescents.Endocr Pract . 2010;16:187-90.
29- Valdés S, Maldonado-Araque C, Lago-Sampedro A, Lillo-Muñoz JA, Garcia-Fuentes E, Perez-Valero V, et al: Reference values for TSH may be inadequate to define hypothyroidism in persons with morbid obesity: Di@bet.es study. Obesity (Silver Spring). 2017;25:788-793.
30- Mukasa K, Noh JY, Kunii Y, Matsumoto M, Sato S, Yasuda S, Suzuki M, Ito K, Ito K: Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases Thyroid . 2011;21:37-41.
31- Azizi G, Keller JM, Lewis M, Piper K, Puett D, Rivenbark KM, Malchoff CD: Association of Hashimoto’s thyroiditis with thyroid cancer.Endocr Relat Cancer . 2014;21:845-52.
32- Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC, Chen H: Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab . 2008;93:809-14.
33- Del Rio P, Montana Montana C, Cozzani F, Rossini M, Loderer T, Dall’Aglio E, Cataldo S, Marina M, Graziano C: Is there a correlation between thyroiditis and thyroid cancer? Endocrine . 2019;66:538–541.
34- Shi L, Li Y, Guan H, Li C, Shi L, Shan Z, Teng W: Usefulness of serum thyrotropin for risk prediction of differentiated thyroid cancers does not apply to microcarcinomas: results of 1,870 Chinese patients with thyroid nodules. Endocr J. 2012;59:973-80.
35- Reinehr T: Obesity and thyroid function. Mol Cell Endocrinol . 2010;316:165-71.
36- Allen N, Desai N, Song C, Yu J, Prasad U, Francis G: Clinical features may help to identify children and adolescents with greatest risk for thyroid nodules. J Endocrinol Invest . 2020;43:925-934.
37- Buscemi S, Massenti FM, Vasto S, Galvano F, Buscemi C, Corleo D, Barile AM, Rosafio G, Rini N, Giordano C: Association of obesity and diabetes with thyroid nodules. Endocrine . 2018;60:339-347.
38- Grani G, Lamartina L, Cantisani V, Maranghi M, Lucia P, Durante C: Interobserver agreement of various thyroid imaging reporting and data systems. Endocr Connect . 2018;7:1-7.
39- Caturegli P, De Remigis A, Rose NR: Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev . 2014;13:391-7.
40- Nakamura H, Usa T, Motomura M, Ichikawa T, Nakao K, Kawasaki E, Tanaka M, Ishikawa K, Eguchi K: Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders. J Endocrinol Invest. 2008;31:861-5.